{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:50:11Z","timestamp":1780379411314,"version":"3.54.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4593,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1995,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>OBJECTIVE The relation between the clinical manifestations of thyroid disease (both hypo and hyper\u2010thyroldism) and tissue sensitivity to catecholamines remains uncertain. It has been suggested that tissue adrenergic responsiveness is decreased in hypothyroldism, but the reports have been conflicting and have invariably focused on a single physiological response. Therefore the aim of the present study was to determine in patients with moderate, short\u2010term, symptomatic hypothyroidism the responses of heart rate, systolic and diastolic blood pressure, forearm blood flow and metabolic rate to adrenaline infused at a rate known to achieve plasma concentrations in the middle of the physiological range.<\/jats:p><jats:p>PATIENTS Ten subjects (5M, age 43 \u00b1 3 years, mean \u00b1 SEM) were studied. All were on thyroxine replacement for hypothyroidism following either thyroidectomy or radioactive iodine and had been biochemically euthyroid for at least 6 months.<\/jats:p><jats:p>DESIGN Studies were performed in random order. One study was undertaken on full replacement therapy and the other after 50 \u03bcg thyroxine daily for 2 weeks. After basal, supine measurements adrenaline was infused at 25 ng\/kg\/min for 30 minutes.<\/jats:p><jats:p>MEASUREMENTS Heart rate, blood pressure, blood glucose, metabolic rate and forearm blood flow were measured at rest and at 10\u2010minute intervals throughout the adrenaline infusion.<\/jats:p><jats:p>RESULTS Free <jats:italic>T<\/jats:italic>4 (10.6 \u00b1 1.3 <jats:italic>vs<\/jats:italic> 17.6 \u00b1 2.0pmol\/l, <jats:italic>P<\/jats:italic> &lt; 0.001) and free <jats:italic>T<\/jats:italic>3 (3.6 \u00b1 0.2 <jats:italic>vs<\/jats:italic> 4.6 \u00b1 0.3 pmol\/l, P &lt; 0.01) concentrations were significantly lower on 50 \u03bcg thyroxine than full replacement therapy. Fasting blood glucose concentrations (4.7 \u00b1 0.2 <jats:italic>vs<\/jats:italic> 4.7 \u00b1 0.1 mmol\/l) were similar. The resting adrenaline concentrations were comparable, 0.29 \u00b1 0.18 and 024 \u00b1 0.14nmol\/l on 50 \u03bcg thyroxine and full replacement therapy respectively, and increased to a similar level (2.36 \u00b1 0.39 and 2.36 \u00b1 0.35 nmol\/l) throughout the adrenaline infusion. The resting heart rate and metabolic rate were significantly lower on 50 \u03bcg thyroxine than full replacement therapy (68 \u00b1 2 <jats:italic>vs<\/jats:italic> 72 \u00b1 3 beats\/min, <jats:italic>P<\/jats:italic> &lt; 0.01; and 4.48 \u00b1 0.35 <jats:italic>vs<\/jats:italic> 4.88 \u00b1 0.39kJ\/min, <jats:italic>P<\/jats:italic> &lt; 0.01) respectively, but the increase in heart rate (7 \u00b1 2 <jats:italic>vs<\/jats:italic> 8 \u00b1 2 beats\/min) and metabolic rate (0.43 \u00b1 0.09 vs 0.43 \u00b1 0.06kJ\/min) did not differ on the two study days. Resting systolic blood pressure, diastolic blood pressure and forearm blood flow were comparable on 50\u03bcg thyroxine and full replacement therapy as were the changes in systolic blood pressure (1 \u00b1 1 <jats:italic>vs<\/jats:italic> 1 \u00b1 1 mmHg), diastolic blood pressure (\u22127 \u00b1 2 vs \u22127 \u00b1 1 mmHg), forearm blood flow (1.4 \u00b1 0.1 vs 1.7 \u00b1 0.2 ml\/min\/100 ml forearm) and blood glucose concentration (0.7 \u00b1 0.1 <jats:italic>vs<\/jats:italic> 0.7 \u00b1 0.1 mmol\/l).<\/jats:p><jats:p>CONCLUSIONS Patients with short\u2010term hypothyroidism appear to have a normal response to adrenaline infusion despite reduced baseline heart rate and metabolic rate. Thus, under physiological and mild pathophysiological conditions there appears to be no evidence of any synergy between thyroid status and sensitivity to catecholamines.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1995.tb00545.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:18:23Z","timestamp":1205749103000},"page":"747-751","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular and metabolic responses to adrenaline infusion in patients with short\u2010term hypothyroidism"],"prefix":"10.1111","volume":"43","author":[{"given":"A. B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"62","article-title":"The effects of triiodothyronine on haemodynamic responses to epinephrine and norepinephrine in man","volume":"157","author":"Aoki V.S.","year":"1967","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_1_3_1","first-page":"362","article-title":"Studies on the reputed augmentation of the cardiovascular effects of the catecholamines in patients with spontaneous hyperthyroidism","volume":"181","author":"Aoki V.S.","year":"1972","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-4-4-378"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-35-3-359"},{"key":"e_1_2_1_6_1","first-page":"163","article-title":"Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema","volume":"45","author":"Christensen N.J.","year":"1973","journal-title":"CIinical Science and Molecular Medicine"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(76)90126-8"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-44-6-1185"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198008213030806"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1088\/0143-0815\/6\/4\/007"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(87)90168-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-23-1-33"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/S1463924684000286"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0025-7125(16)35359-7","article-title":"Clinical application of the basal metabolism test","volume":"34","author":"Kyle L.H.","year":"1950","journal-title":"Medical Clinics of North America"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.25.1.30"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113961"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/clinchem\/24.10.1724","article-title":"Enzymatic fluorometric continuous flow assays for blood glucose, lactate, pyruvate, glycerol and 3\u2010hydroxybutyrate","volume":"24","author":"Lloyd B.","year":"1978","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(85)90072-X"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb00855.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1976.41.4.565"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90182-O"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-3-631"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1953.sp004926"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1995.tb00545.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1995.tb00545.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T18:20:32Z","timestamp":1698258032000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1995.tb00545.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1111\/j.1365-2265.1995.tb00545.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb00545.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}